Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

269 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Safety, pharmacokinetics, and antiretroviral activity of the potent, specific human immunodeficiency virus protease inhibitor nelfinavir: results of a phase I/II trial and extended follow-up in patients infected with human immunodeficiency virus.
Moyle GJ, Youle M, Higgs C, Monaghan J, Prince W, Chapman S, Clendeninn N, Nelson MR. Moyle GJ, et al. Among authors: youle m. J Clin Pharmacol. 1998 Aug;38(8):736-43. doi: 10.1002/j.1552-4604.1998.tb04814.x. J Clin Pharmacol. 1998. PMID: 9725550 Clinical Trial.
Is interruption of HIV therapy always harmful?
Youle M. Youle M. J Antimicrob Chemother. 2000 Feb;45(2):137-8. doi: 10.1093/jac/45.2.137. J Antimicrob Chemother. 2000. PMID: 10660493 No abstract available.
Health economics. Perfect combination.
Youle M, Weston R, Trueman P, Swaden L, Leake H. Youle M, et al. Health Serv J. 1999 Oct 7;109(5675):26-7. Health Serv J. 1999. PMID: 10662318
269 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page